Hemopoietic stem cell transplantation in thalassemia: A report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010

Bone Marrow Transplantation

Volumn 51, Issue 4, 2016, Pages 536-541

  Baronciani, D ^a   Angelucci, E ^a   Potschger, U ^b   Gaziev, J ^c   Yesilipek, A ^d   Zecca, M ^e   Orofino, M G ^f   Giardini, C ^g   Al Ahmari, A ^h   Marktel, S ⁱ   De La Fuente, J ^j   Ghavamzadeh, A ^k   Hussein, A A ^l   Targhetta, C ^a   Pilo, F ^a   Locatelli, F ^m   Dini, G ⁿ   Bader, P ^o   Peters, C ^b  

^a Ospedale Oncologico A Businco   (Italy)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c International Centre for Transplantation in Thalassemia and Sickle Cell Anaemia   (Italy)

^d AKDENIZ UNIVERSITY   (Turkey)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g Ospedali Riuniti Marche Nord   (Italy)

^h KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j St Mary Hospital Medical School   (United Kingdom)

^k TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^l KING HUSSEIN CANCER CENTER   (Jordan)

^m BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁿ EBMT   (Italy)

^o Hospital for Children and Adolescents   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; THALASSEMIA MAJOR; TREATMENT OUTCOME; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEDICAL SOCIETY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REGISTER; SURVIVAL RATE; THALASSEMIA;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SOCIETIES, MEDICAL; SURVIVAL RATE; THALASSEMIA;

EID: 84954526227     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.293     Document Type: Conference Paper

References (20)

1. Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna-Pignatti C, Stefano P et al. Marrow transplantation for thalassaemia. Lancet 1982; 2: 227-229
2. Lucarelli G, Polchi P, Izzi T, Manna M, Agostinelli F, Delfini C et al. Allogeneic marrow transplantation for thalassemia. Exp Hematol 1984; 12: 676-681
3. Angelucci E, Matthes-Martin S, Baronciani D, Bernadine F, Bonanomi S, Cappellini MD et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel. Haematologica 2014; 99: 811-820
4. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828
5. Marubini E, Valsecchi MG (eds). Analysing Survival Data from Clinical Trials and Observational Studies. Wiley: New York, 2004
6. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322: 417-421
7. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993; 329: 840-844
8. Lucarelli G, Galimberti M, Polchi P, Giardini C, Politi P, Baronciani D et al. Marrow transplantation in patients with advanced thalassemia. N Engl J Med 1987; 316: 1050-1055
9. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480-487
10. Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK et al. HLA-matched sibling bone marrow transplantation for beta-thalassemia major. Blood 2011; 117: 1745-1750
11. Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 889-894
12. Angelucci E. Hematopoietic stem cell transplantation in thalassemia. Hematology Am Soc Hematol Educ Program 2010; 2010: 456-462
13. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999; 93: 1164-1167
14. Michlitsch JG, Walters MC. Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mol Med 2008; 8: 675-689
15. Li C, Wu X, Feng X, He Y, Liu H, Pei F et al. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation. Blood 2012; 120: 3875-3881
16. Choudhary D, Sharma S, Gupta N, Kharya G, Pavecha P, Handoo A et al. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from North India. Biol Blood Marrow Transplant 2013; 19: 492-495
17. Agarwal MB. Advances in management of Thalassemia. Indian J Pediatr 2009; 76: 177-184
18. Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A et al. Pretransplant immunosuppression followed by reducedtoxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control. Biol Blood Marrow Transplant 2013; 19: 1259-1262
19. Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A et al. Improved clinical outcomes of high risk beta thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts. PLoS One 2013; 8: e61637
20. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Heir K, Fusil F et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 2010; 467: 318-322